Purple Biotech (PPBT) Dividends Paid - Common (2017 - 2026)
Purple Biotech (PPBT) posted quarterly Dividends Paid - Common of $5.6 million for Q1 2026, down 3.55% year-over-year from $5.8 million in Q1 2025, and up 14.64% quarter-over-quarter from $4.9 million in Q3 2025.
Purple Biotech (PPBT) Dividends Paid - Common (2017 - 2026) Analysis & Trends
Purple Biotech (PPBT) has reported Dividends Paid - Common for 10 consecutive years, with $5.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Dividends Paid - Common fell 3.55% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $15.2 million (up 35.23% YoY), while the FY2023 annual figure was $14.5 million, down 3.6% from the prior year.
- Dividends Paid - Common climbed to $5.6 million in Q1 2026 per PPBT's latest filing, from $4.9 million in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $23.5 million in Q1 2022 and bottomed at -$9.5 million in Q2 2022.
- Historically, Dividends Paid - Common has averaged $5.1 million across 5 years, with a median of $4.9 million in 2025.
- On a YoY basis, Dividends Paid - Common climbed as much as 747.72% in 2022 and fell as far as 2862.61% in 2022.
- Purple Biotech's Dividends Paid - Common stood at $15.0 million in 2022, then fell by 3.6% to $14.5 million in 2023, then tumbled by 107.5% to -$1.1 million in 2024, then soared by 547.15% to $4.9 million in 2025, then increased by 14.64% to $5.6 million in 2026.
- Business Quant data shows PPBT's Dividends Paid - Common at $5.6 million in Q1 2026, $4.9 million in Q3 2025, and -$1.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 34.60 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Purple Biotech | 133.62 | 133.62 | - | -331,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.57 Mn |
| Mar 31, 2026 | 5.57 Mn |
| Sep 30, 2025 | 4.86 Mn |
| Sep 30, 2025 | 4.86 Mn |
| Jun 30, 2025 | -1.04 Mn |
| Jun 30, 2025 | -1.04 Mn |
| Mar 31, 2025 | 5.77 Mn |
| Mar 31, 2025 | 5.77 Mn |
| Sep 30, 2024 | -1.09 Mn |
| Sep 30, 2024 | -1.09 Mn |
| Jun 30, 2024 | -3.46 Mn |
| Jun 30, 2024 | -3.46 Mn |
| Mar 31, 2024 | 9.99 Mn |
| Mar 31, 2024 | 9.99 Mn |
| Dec 31, 2023 | 14.49 Mn |
| Dec 31, 2023 | 14.49 Mn |
| Sep 30, 2023 | -2.10 Mn |
| Sep 30, 2023 | -2.10 Mn |
| Jun 30, 2023 | -4.68 Mn |
| Jun 30, 2023 | -4.68 Mn |